<DOC>
	<DOCNO>NCT02334852</DOCNO>
	<brief_summary>The AF common arrhythmia clinical practice affect 1-2 % general population . It common cause cerebrovascular event ( CVE ) , responsible 25 % ischemic stroke 50 % cardioembolic stroke . The CARMEN-AF registry plan first registry non-valvular AF Mexico national representation , plan specific objective publication . Follow-up period two year plan .</brief_summary>
	<brief_title>Registry Atrial Fibrillation Embolic Risk Mexico</brief_title>
	<detailed_description>The CARMEN-AF registry intend achieve national sample non-valvular AF male female patient older 18 year participation every state Mexico . Thus , wide geographical distribution allow compare health care quality different geographical area patient attend ( Northwest , North , Center , Mexico City , East Southeast ) . Besides , guarantee national representation , principle health institution plan participate , public private one . Primary objective : To know current state thromboprophylaxis non-valvular Atrial Fibrillation ( AF ) Mexico . To evaluate therapeutic behavior accord Clinical Practice Guidelines ( CPG ) baseline one year follow-up , educational strategy increase adherence . Secondary objective : To identify characteristic oral anticoagulant current use Mexico . To analyze efficiency anticoagulation vitamin K antagonists new oral anticoagulant , baseline one year follow-up . Descriptive statistic : For group variable follow descriptive statistic obtain : In continuous variable : mean , standard deviation ( SD ) , standard error , confidence interval ( CI ) 95 % , minimum , percentile 25 , median , percentile75 , maximum , n number lose data . In categorical variable : % total column , n category . Lost data treat new category . Ethical aspect : Every investigator fulfil study accord principle Helsinki declaration . Copies Helsinki Declaration subsequent amendment provide specific request obtain World Medical Association website ( http : //www.wma.net/en/30publications /10policies/b3/index.html ) . The study develop accordance protocol procedure ensure standard Good Clinical Practice ( GCP ) compliance ( 1996 ) . The study conduct accordance guideline Good Epidemiological Practice . Risk-benefit assessment research subject : Patients include study subject experimental consideration . Information sheet inform consent form : As study represent longitudinal observational registry imply therapeutic change , informed consent form contemplate .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Patients document diagnosis AF last six month 12lead electrocardiogram , rhythm strip , Holter monitoring , pacemaker minimum 30 second ( without treatment regardless rhythm enrollment ) Patients present AF ( diagnose standard ECG Holter monitoring ) baseline Patients eligible treatment oral anticoagulant thromboprophylaxis Patients least 1 risk factor thromboembolism ( CVE outside CNS ) accord CHA2DS2VASc AF transient cause ( thyrotoxicosis , alcohol intoxication , myocardial infarction ( MI ) acute phase , pericarditis , myocarditis , electrocution , pulmonary embolism lung disease , electrolyte metabolic disorder , etc ) . AF onset immediate postoperative 3 month cardiac surgery Terminal illness Mental Inability take anticoagulant Inability fulfill followup visit Programming ablation pulmonary vein Pregnant lactating woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>